Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT04541654
- Status
- Recruiting
Conditions
- Clonal Hematopoiesis
- Hereditary Cancer Syndrome
- Li-Fraumeni Syndrome
- Mosaicism
- TP53 Gene Mutation
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Data and Specimen Collection — GENETIC* Provide research team and access to relevant medical records * Answer short questionnaires periodically * Consider consenting to other optional parts of the research such as: * Providing up to 3 tubes (15ml) of blood at or near the time of consent, as approved by treating physician (optional). * Provide a saliva sample (optional). * Provide eyebrow hairs for analysis of DNA from the bulb (15-20 eyebrow plucks) (optional). * Provide permission for obtainment of stored tissue specimens from cancer or pre-cancer surgeries or biopsies from the pathology departments where they have been stored (optional). * Consider inviting relatives to join the study (optional).
Study Details
The purpose of this research study is to learn more about variants in the TP53 gene both associated with Li-Fraumeni Syndrome (LFS), a hereditary cancer risk condition, and TP53 variants found in the blood for other reasons (e.g. ACE/CHIP and mosaicism).
Key Dates
- Start date
- Sep 15, 2020
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Variant in the TP53 Gene in blood or salivaVariant in the TP53 gene found on a blood or saliva test, have a relative with a variant in the TP53 gene, or because participant meets genetic testing criteria for Li-Fraumeni Syndrome (LFS) based on personal or family cancer history
Primary Outcome Measure
Repository of specimens and data [ Time Frame: 5 years or Study closure ]
Central Contacts
- Judy E Garber, MD, MPH617-632-5770
- Sophie Cahill, BS617-632-4795
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02115 | JUNNE KAMIHARA, MD (PRINCIPAL_INVESTIGATOR) |
| Brigham and Women's Hospital | Boston | Massachusetts | 02215 | Judy Garber, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Judy E. Garber | Boston | Massachusetts | 02215 | Judy Garber, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Washington D.C., District of Columbia
- Clinical and Genetic Studies of Li-Fraumeni SyndromeRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Familial Investigations of Childhood Cancer PredispositionRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic EmbryosRecruiting · Stanford University · Sunnyvale, California